Clinical Trial Update: Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of imipenem/cilastatin/relebactam (MK-7655A) in Japanese participants with complicated intra-abdominal infection or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection

Drugs mentioned

• Imipenem+cilastatin/relebactam (MK-7655A) (imipenem/cilastatin/relebactam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection | Phase 3 | Status: COMPLETED | Results posted: 2019-09-17